Dr. Audrey Miklius, MD (she/her) is an Endocrinologist in Dallas, TX with over 16 years of experience. What is your opinion of Dr. Audrey Miklius, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Audrey Miklius, MD has received over $134,205 which includes payments from the following companies:
$62,180.64 from Boehringer Ingelheim Pharmaceuticals, Inc.
$17,529.06 from LILLY USA, LLC
$13,898.01 from AstraZeneca Pharmaceuticals LP
$11,310.27 from Novo Nordisk Inc
$7,855.50 from Tandem Diabetes Care, Inc.
$3,798.69 from Shire North American Group Inc
$2,566.48 from Takeda Pharmaceuticals U.S.A., Inc.
$1,844.16 from Gilead Sciences Inc
$1,800.27 from Takeda Pharmaceuticals America, Inc.
$1,503.35 from Amgen Inc.
$998.08 from Abbott Laboratories
$836.65 from Janssen Pharmaceuticals, Inc
$831.75 from sanofi-aventis U.S. LLC
$808.42 from Radius Health, Inc.
$717.51 from AbbVie, Inc.
$682.53 from MannKind Corporation
$607.21 from Animas Corporation
$451.85 from INSULET CORPORATION
$381.90 from Regeneron Healthcare Solutions, Inc.
$339.20 from Valeritas, Inc.
Payments received by Dr. Audrey Miklius, MD were from the following categories:
$93,918.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!